High Dividend Stock: Shares of this company surged post the announcement of a 120 per cent dividend!
High Dividend Stock: Shares of this company surged post the announcement of a 120 per cent dividend!

High Dividend Stock: Shares of this company surged post the announcement of a 120 per cent dividend!

Shares of the company, one of the top gainers of BSE Healthcare pack, soared over 5 per cent on a more than 6-fold increase in volume!

Mandar Wagh Article rating: 4.3

Shares of the company, one of the top gainers of BSE Healthcare pack, soared over 5 per cent on a more than 6-fold increase in volume!

Multibaggers of 2022: These pharmaceutical stocks more than doubled the wealth of investors! Do you own them?
Multibaggers of 2022: These pharmaceutical stocks more than doubled the wealth of investors! Do you own them?

Multibaggers of 2022: These pharmaceutical stocks more than doubled the wealth of investors! Do you own them?

After a prolonged correction, the index underwent another surge in recent times as healthcare stocks gained momentum due to the deteriorating Covid scenario.

Mandar Wagh Article rating: 5.0

After a prolonged correction, the index underwent another surge in recent times as healthcare stocks gained momentum due to the deteriorating Covid scenario. 

Stock below Rs 20: Don't miss action in this stock that has announced rights issue worth Rs 48,92,04,000!
Stock below Rs 20: Don't miss action in this stock that has announced rights issue worth Rs 48,92,04,000!

Stock below Rs 20: Don't miss action in this stock that has announced rights issue worth Rs 48,92,04,000!

The stock has a PE multiple of 8.98, while the sectoral PE multiple is 32.8, the ROE is 44.60 per cent and the ROCE is 45.74 per cent.

Kiran Shroff Article rating: 4.0

The stock has a PE multiple of 8.98, while the sectoral PE multiple is 32.8, the ROE is 44.60 per cent and the ROCE is 45.74 per cent.

Top gaining stocks: These healthcare stocks surged over 10 per cent despite a sharp decline in domestic markets!
Top gaining stocks: These healthcare stocks surged over 10 per cent despite a sharp decline in domestic markets!

Top gaining stocks: These healthcare stocks surged over 10 per cent despite a sharp decline in domestic markets!

The only sector which was least affected today was the BSE Healthcare Index, which plunged 1.18 per cent to Rs 23,493.96, despite a sharp decline in the domestic market.

Kiran Shroff Article rating: 4.3

The only sector which was least affected today was the BSE Healthcare Index, which plunged 1.18 per cent to Rs 23,493.96, despite a sharp decline in the domestic market.

Watch out for these penny stocks locked in the upper circuit on December 09
Watch out for these penny stocks locked in the upper circuit on December 09

Watch out for these penny stocks locked in the upper circuit on December 09

PSU Banks, FMCG and pharmaceutical companies have witnessed healthy buying interest but IT and teck equities continue to struggle. However, the Indian indices ended the day higher.

Kiran Shroff Article rating: 4.2

About 1,207 shares have advanced, 2,309 declined and 124 are unchanged. PSU Banks, FMCG and pharmaceutical companies have witnessed healthy buying interest but IT and teck equities continue to struggle. However, the Indian indices ended the day higher.

Only buyers: Shares of this pharmaceutical company are locked at 20 per cent upper circuit. Do you own it?
Only buyers: Shares of this pharmaceutical company are locked at 20 per cent upper circuit. Do you own it?

Only buyers: Shares of this pharmaceutical company are locked at 20 per cent upper circuit. Do you own it?

This stock is currently available at a PE multiple of 21.47 and an ROE of 9.68, all of which indicate good management effectiveness.

Kiran Shroff Article rating: 4.3

This stock is currently available at a PE multiple of 21.47 and an ROE of 9.68, all of which indicate good management effectiveness.

Being the top BSE gainer, shares of this pharmaceutical company were locked at the 20 per cent upper circuit! Do you own it?
Being the top BSE gainer, shares of this pharmaceutical company were locked at the 20 per cent upper circuit! Do you own it?

Being the top BSE gainer, shares of this pharmaceutical company were locked at the 20 per cent upper circuit! Do you own it?

In such a weak market, its strong price-volume breakout kept the bulls in the small-cap sector busy.

Mandar Wagh Article rating: 4.7

In such a weak market, its strong price-volume breakout kept the bulls in the small-cap sector busy. 

Heavy buying seen in these small-caps that hit fresh 52 week high on August 18!
Heavy buying seen in these small-caps that hit fresh 52 week high on August 18!

Heavy buying seen in these small-caps that hit fresh 52 week high on August 18!

On BSE, 265 stocks have hit their upper circuits whereas 131 stocks touched their lower circuits.  

Sayali Kotwal Article rating: 4.2

At 2.30 pm on Thursday, the markets were seen recovering from the day’s low as Asia- Pacific markets tumbled following the overnight cooling off of the most recent Wall Street rise.  

Top-performing pharma stocks in July 2022
Top-performing pharma stocks in July 2022

Top-performing pharma stocks in July 2022

The pharmaceutical sector in India ranks third in terms of volume and fourteenth in terms of value (both globally).  

Sayali Kotwal Article rating: 3.7

The pharmaceutical sector in India ranks third in terms of volume and fourteenth in terms of value (both globally).  The domestic market is anticipated to increase three times in the next ten years, according to the Indian Economic Survey 2021.

 

DSIJ MINDSHARE

Mkt Commentary23-Apr, 2024

Penny Stocks23-Apr, 2024

Penny Stocks23-Apr, 2024

Dividend23-Apr, 2024

Penny Stocks23-Apr, 2024

Knowledge

Fundamental21-Apr, 2024

General21-Apr, 2024

Technical19-Apr, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR